Literature DB >> 16567824

Antihypertensive medication prescribing in 27,822 elderly Canadians with diabetes over the past decade.

Finlay A McAlister1, Norman R C Campbell, Minh Duong-Hua, Zhongliang Chen, Karen Tu.   

Abstract

OBJECTIVE: The purpose of this study was to examine whether prescribing practices for elderly individuals with diabetes and hypertension changed over the past decade. RESEARCH DESIGN AND METHODS: We linked the Ontario Diabetes Database and four administrative databases in Ontario, Canada, to identify 27,822 patients >65 years of age who had diabetes and were newly treated for hypertension between 1 January 1995 and 31 December 2001. All patients were followed for 2 years after their initial antihypertensive medication prescription.
RESULTS: The 27,822 patients in this study (mean age 72 years, 51% men) were treated with oral hypoglycemic agents alone (n = 17,128 patients, 62%), insulin alone (n = 2,346, 8%), both oral hypoglycemic agents and insulin (n = 2,205, 8%), or diet alone (n = 6,143, 22%). Management within the first 2 years of hypertension diagnosis consisted of antihypertensive monotherapy in 20,183 patients (73%), two antihypertensive drugs in 6,207 (22%), and three or more drugs in 1,432 (5%); the most frequently chosen antihypertensive drugs were ACE inhibitors (68%), thiazides (15%), and calcium channel blockers (9%). Between 1995 and 2001, physician prescribing practices changed: the population-adjusted rates of antihypertensive drug prescribing increased by 46% (95% CI 33-55%), the proportion of initial antihypertensive prescriptions for ACE inhibitors increased from 54 to 76% (P < 0.0001), and the use of multiple antihypertensive agents within the first 2 years of diagnosis increased from 21 to 32% (P < 0.0001).
CONCLUSIONS: Antihypertensive prescribing patterns in elderly individuals with diabetes changed over the past decade in Ontario in directions consistent with the evolving evidence base.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16567824     DOI: 10.2337/diacare.29.04.06.dc05-1875

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  7 in total

1.  The long-term effects of stillbirth on women with and without gestational diabetes: a population-based cohort study.

Authors:  Basilio Pintaudi; Giuseppe Lucisano; Fabio Pellegrini; Antonio D'Ettorre; Vito Lepore; Giorgia De Berardis; Marco Scardapane; Giacoma Di Vieste; Maria Chiara Rossi; Michele Sacco; Gianni Tognoni; Antonio Nicolucci
Journal:  Diabetologia       Date:  2014-10-14       Impact factor: 10.122

2.  From pharmaco-therapy to pharmaco-prevention: trends in prescribing to older adults in Ontario, Canada, 1997-2006.

Authors:  Jana M Bajcar; Li Wang; Rahim Moineddin; Jason X Nie; C Shawn Tracy; Ross Eg Upshur
Journal:  BMC Fam Pract       Date:  2010-10-07       Impact factor: 2.497

3.  Diminishing efficacy of combination therapy, response-heterogeneity, and treatment intolerance limit the attainability of tight risk factor control in patients with diabetes.

Authors:  Justin W Timbie; Rodney A Hayward; Sandeep Vijan
Journal:  Health Serv Res       Date:  2010-01-08       Impact factor: 3.402

Review 4.  Canadian Hypertension Education Program: the evolution of hypertension management guidelines in Canada.

Authors:  Ross D Feldman; Norman R C Campbell; Katherine Wyard
Journal:  Can J Cardiol       Date:  2008-06       Impact factor: 5.223

5.  A nationwide assessment of blood pressure control and the associated factors in Chinese type 2 diabetes mellitus patients.

Authors:  Yu-Qing Zhang; Yong Li; Yu-Gang Dong; Yan-Hua Wu; Rui Bian; Ji-Hu Li; Li-Nong Ji
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-10-11       Impact factor: 3.738

6.  The darkening cloud of diabetes: do trends in cardiovascular risk management provide a silver lining?

Authors:  Dean T Eurich; John-Michael Gamble; Scot H Simpson; Jeffrey A Johnson
Journal:  Diabetes Care       Date:  2008-10-07       Impact factor: 17.152

7.  Is cardiovascular risk reduction therapy effective in South Asian, Chinese and other patients with diabetes? A population-based cohort study from Canada.

Authors:  Calvin H Ke; Steve Morgan; Kate Smolina; Danijela Gasevic; Hong Qian; Nadia A Khan
Journal:  BMJ Open       Date:  2017-08-31       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.